 | • レポートコード：MRC2312MG07479 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥455,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥682,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のオンボディインジェクター市場規模と予測を収録しています。・世界のオンボディインジェクター市場：売上、2018年-2023年、2024年-2029年 ・世界のオンボディインジェクター市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のオンボディインジェクター市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「電子式インジェクター」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 オンボディインジェクターのグローバル主要企業は、West Pharmaceutical Services、 Insulet、 Gerresheimer、 United Therapeutics、 CC Bio、 BD、 Ypsomed、 Enable Injections、 Nemera、 Stevanato Group、 Sonceboz、 Lohmann Therapie-Systeme、 Elcam Drug Delivery Devices (E3D)などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、オンボディインジェクターのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のオンボディインジェクター市場：タイプ別、2018年-2023年、2024年-2029年 世界のオンボディインジェクター市場：タイプ別市場シェア、2022年 ・電子式インジェクター、機械式インジェクター 世界のオンボディインジェクター市場：用途別、2018年-2023年、2024年-2029年 世界のオンボディインジェクター市場：用途別市場シェア、2022年 ・腫瘍免疫学、循環器疾患、神経疾患、その他 世界のオンボディインジェクター市場：地域・国別、2018年-2023年、2024年-2029年 世界のオンボディインジェクター市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるオンボディインジェクターのグローバル売上、2018年-2023年 ・主要企業におけるオンボディインジェクターのグローバル売上シェア、2022年 ・主要企業におけるオンボディインジェクターのグローバル販売量、2018年-2023年 ・主要企業におけるオンボディインジェクターのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 West Pharmaceutical Services、 Insulet、 Gerresheimer、 United Therapeutics、 CC Bio、 BD、 Ypsomed、 Enable Injections、 Nemera、 Stevanato Group、 Sonceboz、 Lohmann Therapie-Systeme、 Elcam Drug Delivery Devices (E3D) ************************************************************* ・調査・分析レポートの概要 オンボディインジェクター市場の定義 市場セグメント 世界のオンボディインジェクター市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のオンボディインジェクター市場規模 世界のオンボディインジェクター市場規模：2022年 VS 2029年 世界のオンボディインジェクター市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのオンボディインジェクターの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のオンボディインジェクター製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：電子式インジェクター、機械式インジェクター オンボディインジェクターのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：腫瘍免疫学、循環器疾患、神経疾患、その他 オンボディインジェクターの用途別グローバル売上・予測 ・地域別市場分析 地域別オンボディインジェクター市場規模 2022年と2029年 地域別オンボディインジェクター売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） West Pharmaceutical Services、 Insulet、 Gerresheimer、 United Therapeutics、 CC Bio、 BD、 Ypsomed、 Enable Injections、 Nemera、 Stevanato Group、 Sonceboz、 Lohmann Therapie-Systeme、 Elcam Drug Delivery Devices (E3D) ... |
This research report provides a comprehensive analysis of the On-body Injectors market, focusing on the current trends, market dynamics, and future prospects. The report explores the global On-body Injectors market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of On-body Injectors, challenges faced by the industry, and potential opportunities for market players.
The global On-body Injectors market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The On-body Injectors market presents opportunities for various stakeholders, including Immuno-oncology, Cardiovascular Diseases. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in On-body Injectors market. Additionally, the growing consumer demand present avenues for market expansion.
The global On-body Injectors market was valued at US$ 135.8 million in 2022 and is projected to reach US$ 352.4 million by 2029, at a CAGR of 15.8% during the forecast period.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
Key Features:
The research report on the On-body Injectors market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the On-body Injectors market.
Market Overview: The report provides a comprehensive overview of the On-body Injectors market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Electronic Injectors, Mechanical Injectors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the On-body Injectors market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the On-body Injectors market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the On-body Injectors market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the On-body Injectors market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the On-body Injectors market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the On-body Injectors market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for On-body Injectors, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the On-body Injectors market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Electronic Injectors
Mechanical Injectors
Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Global On-body Injectors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Outline of Major Chapters:
Chapter 1: Introduces the definition of On-body Injectors, market overview.
Chapter 2: Global On-body Injectors market size in revenue and volume.
Chapter 3: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global On-body Injectors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 On-body Injectors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global On-body Injectors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global On-body Injectors Overall Market Size
2.1 Global On-body Injectors Market Size: 2022 VS 2029
2.2 Global On-body Injectors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global On-body Injectors Sales: 2018-2029
3 Company Landscape
3.1 Top On-body Injectors Players in Global Market
3.2 Top Global On-body Injectors Companies Ranked by Revenue
3.3 Global On-body Injectors Revenue by Companies
3.4 Global On-body Injectors Sales by Companies
3.5 Global On-body Injectors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 On-body Injectors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers On-body Injectors Product Type
3.8 Tier 1, Tier 2 and Tier 3 On-body Injectors Players in Global Market
3.8.1 List of Global Tier 1 On-body Injectors Companies
3.8.2 List of Global Tier 2 and Tier 3 On-body Injectors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global On-body Injectors Market Size Markets, 2022 & 2029
4.1.2 Electronic Injectors
4.1.3 Mechanical Injectors
4.2 By Type – Global On-body Injectors Revenue & Forecasts
4.2.1 By Type – Global On-body Injectors Revenue, 2018-2023
4.2.2 By Type – Global On-body Injectors Revenue, 2024-2029
4.2.3 By Type – Global On-body Injectors Revenue Market Share, 2018-2029
4.3 By Type – Global On-body Injectors Sales & Forecasts
4.3.1 By Type – Global On-body Injectors Sales, 2018-2023
4.3.2 By Type – Global On-body Injectors Sales, 2024-2029
4.3.3 By Type – Global On-body Injectors Sales Market Share, 2018-2029
4.4 By Type – Global On-body Injectors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global On-body Injectors Market Size, 2022 & 2029
5.1.2 Immuno-oncology
5.1.3 Cardiovascular Diseases
5.1.4 Neurological Diseases
5.1.5 Others
5.2 By Application – Global On-body Injectors Revenue & Forecasts
5.2.1 By Application – Global On-body Injectors Revenue, 2018-2023
5.2.2 By Application – Global On-body Injectors Revenue, 2024-2029
5.2.3 By Application – Global On-body Injectors Revenue Market Share, 2018-2029
5.3 By Application – Global On-body Injectors Sales & Forecasts
5.3.1 By Application – Global On-body Injectors Sales, 2018-2023
5.3.2 By Application – Global On-body Injectors Sales, 2024-2029
5.3.3 By Application – Global On-body Injectors Sales Market Share, 2018-2029
5.4 By Application – Global On-body Injectors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global On-body Injectors Market Size, 2022 & 2029
6.2 By Region – Global On-body Injectors Revenue & Forecasts
6.2.1 By Region – Global On-body Injectors Revenue, 2018-2023
6.2.2 By Region – Global On-body Injectors Revenue, 2024-2029
6.2.3 By Region – Global On-body Injectors Revenue Market Share, 2018-2029
6.3 By Region – Global On-body Injectors Sales & Forecasts
6.3.1 By Region – Global On-body Injectors Sales, 2018-2023
6.3.2 By Region – Global On-body Injectors Sales, 2024-2029
6.3.3 By Region – Global On-body Injectors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America On-body Injectors Revenue, 2018-2029
6.4.2 By Country – North America On-body Injectors Sales, 2018-2029
6.4.3 US On-body Injectors Market Size, 2018-2029
6.4.4 Canada On-body Injectors Market Size, 2018-2029
6.4.5 Mexico On-body Injectors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe On-body Injectors Revenue, 2018-2029
6.5.2 By Country – Europe On-body Injectors Sales, 2018-2029
6.5.3 Germany On-body Injectors Market Size, 2018-2029
6.5.4 France On-body Injectors Market Size, 2018-2029
6.5.5 U.K. On-body Injectors Market Size, 2018-2029
6.5.6 Italy On-body Injectors Market Size, 2018-2029
6.5.7 Russia On-body Injectors Market Size, 2018-2029
6.5.8 Nordic Countries On-body Injectors Market Size, 2018-2029
6.5.9 Benelux On-body Injectors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia On-body Injectors Revenue, 2018-2029
6.6.2 By Region – Asia On-body Injectors Sales, 2018-2029
6.6.3 China On-body Injectors Market Size, 2018-2029
6.6.4 Japan On-body Injectors Market Size, 2018-2029
6.6.5 South Korea On-body Injectors Market Size, 2018-2029
6.6.6 Southeast Asia On-body Injectors Market Size, 2018-2029
6.6.7 India On-body Injectors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America On-body Injectors Revenue, 2018-2029
6.7.2 By Country – South America On-body Injectors Sales, 2018-2029
6.7.3 Brazil On-body Injectors Market Size, 2018-2029
6.7.4 Argentina On-body Injectors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa On-body Injectors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa On-body Injectors Sales, 2018-2029
6.8.3 Turkey On-body Injectors Market Size, 2018-2029
6.8.4 Israel On-body Injectors Market Size, 2018-2029
6.8.5 Saudi Arabia On-body Injectors Market Size, 2018-2029
6.8.6 UAE On-body Injectors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 West Pharmaceutical Services
7.1.1 West Pharmaceutical Services Company Summary
7.1.2 West Pharmaceutical Services Business Overview
7.1.3 West Pharmaceutical Services On-body Injectors Major Product Offerings
7.1.4 West Pharmaceutical Services On-body Injectors Sales and Revenue in Global (2018-2023)
7.1.5 West Pharmaceutical Services Key News & Latest Developments
7.2 Insulet
7.2.1 Insulet Company Summary
7.2.2 Insulet Business Overview
7.2.3 Insulet On-body Injectors Major Product Offerings
7.2.4 Insulet On-body Injectors Sales and Revenue in Global (2018-2023)
7.2.5 Insulet Key News & Latest Developments
7.3 Gerresheimer
7.3.1 Gerresheimer Company Summary
7.3.2 Gerresheimer Business Overview
7.3.3 Gerresheimer On-body Injectors Major Product Offerings
7.3.4 Gerresheimer On-body Injectors Sales and Revenue in Global (2018-2023)
7.3.5 Gerresheimer Key News & Latest Developments
7.4 United Therapeutics
7.4.1 United Therapeutics Company Summary
7.4.2 United Therapeutics Business Overview
7.4.3 United Therapeutics On-body Injectors Major Product Offerings
7.4.4 United Therapeutics On-body Injectors Sales and Revenue in Global (2018-2023)
7.4.5 United Therapeutics Key News & Latest Developments
7.5 CC Bio
7.5.1 CC Bio Company Summary
7.5.2 CC Bio Business Overview
7.5.3 CC Bio On-body Injectors Major Product Offerings
7.5.4 CC Bio On-body Injectors Sales and Revenue in Global (2018-2023)
7.5.5 CC Bio Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD On-body Injectors Major Product Offerings
7.6.4 BD On-body Injectors Sales and Revenue in Global (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Ypsomed
7.7.1 Ypsomed Company Summary
7.7.2 Ypsomed Business Overview
7.7.3 Ypsomed On-body Injectors Major Product Offerings
7.7.4 Ypsomed On-body Injectors Sales and Revenue in Global (2018-2023)
7.7.5 Ypsomed Key News & Latest Developments
7.8 Enable Injections
7.8.1 Enable Injections Company Summary
7.8.2 Enable Injections Business Overview
7.8.3 Enable Injections On-body Injectors Major Product Offerings
7.8.4 Enable Injections On-body Injectors Sales and Revenue in Global (2018-2023)
7.8.5 Enable Injections Key News & Latest Developments
7.9 Nemera
7.9.1 Nemera Company Summary
7.9.2 Nemera Business Overview
7.9.3 Nemera On-body Injectors Major Product Offerings
7.9.4 Nemera On-body Injectors Sales and Revenue in Global (2018-2023)
7.9.5 Nemera Key News & Latest Developments
7.10 Stevanato Group
7.10.1 Stevanato Group Company Summary
7.10.2 Stevanato Group Business Overview
7.10.3 Stevanato Group On-body Injectors Major Product Offerings
7.10.4 Stevanato Group On-body Injectors Sales and Revenue in Global (2018-2023)
7.10.5 Stevanato Group Key News & Latest Developments
7.11 Sonceboz
7.11.1 Sonceboz Company Summary
7.11.2 Sonceboz Business Overview
7.11.3 Sonceboz On-body Injectors Major Product Offerings
7.11.4 Sonceboz On-body Injectors Sales and Revenue in Global (2018-2023)
7.11.5 Sonceboz Key News & Latest Developments
7.12 Lohmann Therapie-Systeme
7.12.1 Lohmann Therapie-Systeme Company Summary
7.12.2 Lohmann Therapie-Systeme Business Overview
7.12.3 Lohmann Therapie-Systeme On-body Injectors Major Product Offerings
7.12.4 Lohmann Therapie-Systeme On-body Injectors Sales and Revenue in Global (2018-2023)
7.12.5 Lohmann Therapie-Systeme Key News & Latest Developments
7.13 Elcam Drug Delivery Devices (E3D)
7.13.1 Elcam Drug Delivery Devices (E3D) Company Summary
7.13.2 Elcam Drug Delivery Devices (E3D) Business Overview
7.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Major Product Offerings
7.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales and Revenue in Global (2018-2023)
7.13.5 Elcam Drug Delivery Devices (E3D) Key News & Latest Developments
8 Global On-body Injectors Production Capacity, Analysis
8.1 Global On-body Injectors Production Capacity, 2018-2029
8.2 On-body Injectors Production Capacity of Key Manufacturers in Global Market
8.3 Global On-body Injectors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 On-body Injectors Supply Chain Analysis
10.1 On-body Injectors Industry Value Chain
10.2 On-body Injectors Upstream Market
10.3 On-body Injectors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 On-body Injectors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer